Search research articles
Contact Us
Filters
Showing results (71-80 of 397) with videos related to
Page
of 40
Sort By:
Journal of Immunotherapy and Precision Oncology
|
April 11, 2025
Pembrolizumab in Patients with Advanced Miscellaneous Rare Cancers: Results from a Phase 2 Basket Trial
Mirella Nardo, Camila Braganca Xavier, Bettzy Stephen, et al.
Cureus
|
March 28, 2019
Trends in Epidemiology: Analysis of Risk Factors and Outcomes of Infective Endocarditis: A Retrospective Study (2009-2015)
Aung Naing Lin, Htoo Kyaw, Kyawzaw Lin, et al.
Plos One
|
April 16, 2011
Targeted morphoproteomic profiling of Ewing's sarcoma treated with insulin-like growth factor 1 receptor (IGF1R) inhibitors: response/resistance signatures
Vivek Subbiah, Aung Naing, Robert E Brown, et al.
Cancers
|
August 12, 2023
A Phase II Clinical Trial of Pembrolizumab Efficacy and Safety in Advanced Renal Medullary Carcinoma
Chijioke Nze, Pavlos Msaouel, Mohamed H Derbala, et al.
Cell Cycle (Georgetown, Tex.)
|
October 16, 2015
Novel phase I study combining G1 phase, S phase, and G2/M phase cell cycle inhibitors in patients with advanced malignancies
Rajul K Jain, David S Hong, Aung Naing, et al.
Journal of Immunotherapy and Precision Oncology
|
October 27, 2025
Phase 2 Study of Monotherapy with Pembrolizumab for Advanced Adrenocortical Carcinoma
Brenda Chahla, Bettzy Stephen, Juhee Song, et al.
Journal of Human Evolution
|
June 22, 2026
A new large-bodied sivaladapid primate from the Eocene of Myanmar resolves phylogenetic conflict obscuring the anthropoid status of Amphipithecidae
Yaowalak Chaimanee, Laurent Marivaux, K Christopher Beard, et al.
The European Physical Journal. D, Atomic, Molecular, and Optical Physics
|
June 28, 2024
High resolution X-ray spectra of the time evolution of emission from metastable electronic states of highly charged Ni-like ions
Timothy Burke, Endre Takacs, Dipti, et al.
Investigational New Drugs
|
April 24, 2013
Phase I dose-escalating study of TAS-106 in combination with carboplatin in patients with solid tumors
Aung Naing, Siqing Fu, Ralph G Zinner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 29, 2012
Phase I study of the antiangiogenic antibody bevacizumab and the mTOR/hypoxia-inducible factor inhibitor temsirolimus combined with liposomal doxorubicin: tolerance and biological activity
John Moroney, Siqing Fu, Stacy Moulder, et al.
Page
of 40
Search research articles
Search
Showing results (71-80 of 397) with videos related to
Sort By:
Page
of 40
Journal of Immunotherapy and Precision Oncology
|
April 11, 2025
Pembrolizumab in Patients with Advanced Miscellaneous Rare Cancers: Results from a Phase 2 Basket Trial
Mirella Nardo, Camila Braganca Xavier, Bettzy Stephen, et al.
Cureus
|
March 28, 2019
Trends in Epidemiology: Analysis of Risk Factors and Outcomes of Infective Endocarditis: A Retrospective Study (2009-2015)
Aung Naing Lin, Htoo Kyaw, Kyawzaw Lin, et al.
Plos One
|
April 16, 2011
Targeted morphoproteomic profiling of Ewing's sarcoma treated with insulin-like growth factor 1 receptor (IGF1R) inhibitors: response/resistance signatures
Vivek Subbiah, Aung Naing, Robert E Brown, et al.
Cancers
|
August 12, 2023
A Phase II Clinical Trial of Pembrolizumab Efficacy and Safety in Advanced Renal Medullary Carcinoma
Chijioke Nze, Pavlos Msaouel, Mohamed H Derbala, et al.
Cell Cycle (Georgetown, Tex.)
|
October 16, 2015
Novel phase I study combining G1 phase, S phase, and G2/M phase cell cycle inhibitors in patients with advanced malignancies
Rajul K Jain, David S Hong, Aung Naing, et al.
Journal of Immunotherapy and Precision Oncology
|
October 27, 2025
Phase 2 Study of Monotherapy with Pembrolizumab for Advanced Adrenocortical Carcinoma
Brenda Chahla, Bettzy Stephen, Juhee Song, et al.
Journal of Human Evolution
|
June 22, 2026
A new large-bodied sivaladapid primate from the Eocene of Myanmar resolves phylogenetic conflict obscuring the anthropoid status of Amphipithecidae
Yaowalak Chaimanee, Laurent Marivaux, K Christopher Beard, et al.
The European Physical Journal. D, Atomic, Molecular, and Optical Physics
|
June 28, 2024
High resolution X-ray spectra of the time evolution of emission from metastable electronic states of highly charged Ni-like ions
Timothy Burke, Endre Takacs, Dipti, et al.
Investigational New Drugs
|
April 24, 2013
Phase I dose-escalating study of TAS-106 in combination with carboplatin in patients with solid tumors
Aung Naing, Siqing Fu, Ralph G Zinner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 29, 2012
Phase I study of the antiangiogenic antibody bevacizumab and the mTOR/hypoxia-inducible factor inhibitor temsirolimus combined with liposomal doxorubicin: tolerance and biological activity
John Moroney, Siqing Fu, Stacy Moulder, et al.
Page
of 40